U.S. Pharmaceuticals & Biotech Undervalued Small Caps

Abeona Therapeutics

Market Cap: US$269.3m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Zevra Therapeutics

Market Cap: US$502.7m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

SIGA Technologies

Market Cap: US$456.2m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Azenta

Market Cap: US$1.2b

Provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.